AIM ImmunoTech Inc

ASE:AIM   4:00:00 PM EDT
0.45
+0.01 (+2.02%)
Earnings Announcements

Aim Immunotech Reports Third Quarter 2022 Financial Results

Published: 11/15/2022 12:19 GMT
AIM ImmunoTech Inc (AIM) - Aim Immunotech Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Aim Immunotech Inc - Cash Position Expected to Fund Operations Through End of 2023.
Aim Immunotech Inc - Qtrly Net Loss per Share $0.13.
Aim Immunotech Inc - As of September 30, 2022, Aim Reported Cash and Cash Equivalents of $36.7 Million.
Revenue is expected to be $0.18 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.